COLL vs OKE · P/E 17, rev $181.9M vs P/E 15, rev $21.70B
Collegium Pharmaceutical Inc (COLL) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the COLL and OKE stock pages for the full models.
Not investment advice.